Jonathan C. Javitt - 01 Jun 2022 Form 4/A - Amendment Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Chief Scientist, Director, 10%+ Owner
Signature
/s/ Jonathan C. Javitt
Issuer symbol
NRXP
Transactions as of
01 Jun 2022
Net transactions value
+$58,000
Form type
4/A - Amendment
Filing time
02 Jun 2022, 09:46:10 UTC
Date Of Original Report
02 Jun 2022
Previous filing
10 Jun 2021
Next filing
09 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock Purchase $58,000 +100,000 +216% $0.5800 146,332 01 Jun 2022 Direct
holding NRXP Common Stock 13,299,997 01 Jun 2022 By Trust F1, F2
holding NRXP Common Stock 1,422,000 01 Jun 2022 By Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects charitable donations of 49,000 shares of Common Stock that occurred in December 2021.
F2 Held by the Jonathan Javitt Living Trust of which the Reporting Person is trustee.
F3 Held by The Javitt 2012 Irrevocable Dynasty Trust of which the Reporting Person is the Grantor.

Remarks:

The Form 4, as originally filed, incorrectly reported the price and is corrected herein.